Evidence map›Paper›PMID 32456708›Full record

ArticleBMC research notes2020

Socioeconomic impacts of elimination of onchocerciasis in Abu-Hamed focus, northern Sudan: lessons after elimination.

Ayman Ahmed, Anas Elbashir, Asgad A Mohamed, Asha A Alim, Asia Mubarak, Duaa Abdelrahman, Eilaf Mohammed, Nouh S Mohamed, Arwa H Elaagip, Isam M A Zarroug and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. First report of epidemic dengue fever and malaria co-infections among internally displaced persons in humanitarian camps of North Darfur, Sudan.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  14. The first laboratory-confirmed imported infections of SARS-CoV-2 in Sudan.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Ayman AhmedInstitute of Endemic Diseases, University of Khartoum, Khartoum, Sudan. ayman.ame.ahmed@gmail.com.ORCID http://orcid.org/0000-0002-9516-9508
Anas ElbashirPublic and Tropical Health Programmes, University of Medical Sciences and Technology, Khartoum, Sudan.
Asgad A MohamedPublic and Tropical Health Programmes, University of Medical Sciences and Technology, Khartoum, Sudan.
Asha A AlimPublic and Tropical Health Programmes, University of Medical Sciences and Technology, Khartoum, Sudan.
Asia MubarakPublic and Tropical Health Programmes, University of Medical Sciences and Technology, Khartoum, Sudan.
Duaa AbdelrahmanPublic and Tropical Health Programmes, University of Medical Sciences and Technology, Khartoum, Sudan.
Eilaf MohammedPublic and Tropical Health Programmes, University of Medical Sciences and Technology, Khartoum, Sudan.
Nouh S MohamedDepartment of Parasitology and Medical Entomology, Faculty of Medical Laboratory Sciences, Nile University, Khartoum, Sudan.
Arwa H ElaagipDepartment of Parasitology and Medical Entomology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan.
Isam M A ZarrougOnchocerciasis Control/Elimination Programme, National Programme for Prevention of Blindness (NPPB), Federal Ministry of Health, Khartoum, Sudan.
Noma MounkailaPublic and Tropical Health Programmes, University of Medical Sciences and Technology, Khartoum, Sudan.
Hanan TahirPublic and Tropical Health Programmes, University of Medical Sciences and Technology, Khartoum, Sudan.
University of Medical Sciences and Technology · SDFederal Ministry of Health · SDUniversity of Khartoum · SD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesOnchocerciasis is one of the most devastating neglected tropical diseases and it is mostly prevalent in Africa. The disease has important heavy social and economic burdens on the infected populations including low productivity, unemployment, social isolation, and stigma. A cross-sectional study was implemented using a well-established questionnaire to investigate the socio-economic impacts of Onchocerciasis elimination in Abu-Hamed, River Nile State, Sudan in 2015; 512 participants in ten affected communities were interviewed.

resultsOur findings revealed that these communities are recovering from the social and economic burden of the diseases. Ninety percent of the research participants reported general satisfaction about elimination of the disease in their community, 48.3% of them attended secondary school or university. Only 0.6% reported unemployment. Also, 25.3% and 24.7% of the participants were workers and farmers respectively. Except about the vector biting and nuisance, the majority of the respondents (90%) had no complain related to the disease after the elimination. Also, 90.5% of the participants reported either stable or increase in their work performance during the last 12 months. About 93.8% of the respondents were engaged in normal daily life activities and involved in happy events like marriage and giving birth during the last 12 months.

Indexed as

AdolescentAdultAgedAged, 80 and overChildCross-Sectional StudiesDemographyDisease EradicationFemaleHumansMaleMiddle AgedNeglected DiseasesOnchocerciasisSocioeconomic FactorsSudanAbu-HamedEliminationNTDsOnchocerciasisSocioeconomicSudan

Identifiers

PMID32456708
PMCPMC7249366
OpenAlexW3029210661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.